Nisa Investment Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-410
| Closed | -$6.47K | – | 2784 |
|
|
2023
Q3 | $6.47K | Sell |
410
-1,240
| -75% | -$19.6K | ﹤0.01% | 2256 |
|
|
2023
Q2 | $32.1K | Buy |
1,650
+1,240
| +302% | +$24.1K | ﹤0.01% | 1911 |
|
|
2023
Q1 | $12K | Hold |
410
| – | – | ﹤0.01% | 2138 |
|
|
2022
Q4 | $12K | Hold |
410
| – | – | ﹤0.01% | 2180 |
|
|
2022
Q3 | $13K | Sell |
410
-207
| -34% | -$6.56K | ﹤0.01% | 2154 |
|
|
2022
Q2 | $27K | Buy |
617
+70
| +13% | +$3.06K | ﹤0.01% | 1959 |
|
|
2022
Q1 | $27K | Sell |
547
-2,538
| -82% | -$125K | ﹤0.01% | 1992 |
|
|
2021
Q4 | $142K | Buy |
3,085
+50
| +2% | +$2.3K | ﹤0.01% | 1386 |
|
|
2021
Q3 | $169 | Sell |
3,035
-1,437
| -32% | -$80 | ﹤0.01% | 1471 |
|
|
2021
Q2 | $191 | Sell |
4,472
-1,000
| -18% | -$43 | ﹤0.01% | 1426 |
|
|
2021
Q1 | $228 | Hold |
5,472
| – | – | ﹤0.01% | 1442 |
|
|
2020
Q4 | $255K | Buy |
5,472
+3,098
| +130% | +$144K | ﹤0.01% | 1368 |
|
|
2020
Q3 | $101K | Buy |
+2,374
| New | +$101K | ﹤0.01% | 1544 |
|